Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,682,414
+$194,609 QoQ
Shares Held
49,020
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#203
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $56,834,770 across 10 Drug Manufacturers - General names. NVS ranks #2 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
103,992 | $26,410,848 | |
| 2 | NVS |
Novartis AG
This page
|
49,020 | $7,682,414 | |
| 3 | ABBV |
AbbVie Inc.
|
29,986 | $7,545,677 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,965 | $6,549,002 | |
| 5 | AZN |
Astrazeneca PLC
|
32,459 | $6,154,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,077 | $1,291,786 | |
| 7 | AMGN |
Amgen Inc
|
3,003 | $1,087,446 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,849 | $106,539 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,682,414 | 49,020 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $7,487,805 | 49,020 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,758,387 | 49,020 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,286,324 | 49,020 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $5,931,910 | 49,020 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,381,139 | 48,270 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,697,153 | 48,270 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $5,552,015 | 48,270 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $5,138,824 | 48,270 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,669,157 | 48,270 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $5,156,537 | 51,070 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $5,201,990 | 51,070 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $5,128,246 | 50,820 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,675,440 | 50,820 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,905,230 | 54,070 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,653,800 | 48,070 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,562,516 | 42,145 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $3,184,008 | 36,285 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,593,048 | 29,645 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,361,888 | 28,881 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,604,902 | 28,550 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,440,454 | 28,550 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,695,976 | 28,550 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,482,708 | 28,550 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,290,491 | 26,225 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,991,167 | 24,150 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||